We explored the immune characteristics of TLE3 in the tumor microenvironment (TME), including tumor-infiltrating lymphocytes, immunostimulatory factors, MHC molecules, chemokines, receptors, and immune checkpoints. The gene discussed is HLA-C; the disease is neoplasm.